FDA approves fam-trastuzumab deruxtecan-Nxki for unresectable or metastatic HER2-Positive Solid Tumors

2 weeks ago
Taylor Pak

By: Dr. Anish ShahBronx-Lebanon Hospital; Bronx, NY On April 5, 2024, the Food and Drug Administration granted accelerated approval forfam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi…

Immune Checkpoint Inhibitors

1 month ago

By: Dr. Arya Mariam Roy Roswell Park Comprehensive Cancer Center What are immune checkpoint inhibitors? Immune checkpoint inhibitors are a…

FDA Approves Amivantamab for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

1 month ago

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On March 1, 2024, the U.S. Food and Drug Administration approved amivantamab- vmjw (Rybrevant,…

FDA Approves Osimertinib Plus Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer with EGFR Mutation

2 months ago

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY The FDA gave its approval for the use of osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP)…

FDA Grants Accelerated Approval to Lifileucel for Previously Treated Metastatic Melanoma

2 months ago

By: Dr. Anish ShahBronx-Lebanon Hospital; Bronx, NY On February 16, 2024, the U.S. Food and Drug Administration granted accelerated approval to lifileucel (Amtagvi).…

FDA Approves Tepotinib for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Skipping Alterations

2 months ago

By: Dr. Anish ShahBronx-Lebanon Hospital; Bronx, NY On February 15, 2024, the U.S. Food and Drug Administration granted regular approval to tepotinib (Tepmetko)…

FDA Approves Irinotecan Liposome for Metastatic Pancreatic Adenocarcinoma

2 months ago

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On February 13, 2024, the U.S. Food and Drug Administration granted approval for the…

FDA approves eflornithine for high-risk neuroblastoma following partial response to prior therapy.

4 months ago

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On December 13, 2023, the U.S. Food and Drug Administration granted approval to eflornithine…

FDA Approves Enfortumab and Pembrolizumab for Urothelial Cancer in an advanced or metastatic stage

4 months ago

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY The U.S. Food and Drug Administration gave its approval for the use of enfortumab…

FDA Approves Belzutifan for Advanced Renal Cell Carcinoma with prior therapy.

4 months ago

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On December 14, 2023, the U.S. Food and Drug Administration granted approval to belzutifan…